Materiały źródłowe

• #1 Prevention, Diagnosis, and Management of Serotonin Syndrome | AAFP

  https://www.aafp.org/pubs/afp/issues/2010/0501/p1139.html

  Prevention of serotonin syndrome requires clinical awareness of the toxic potential of serotonergic agents. […] Avoiding the combined use of serotonin-augmenting drugs is essential. Physicians should modify prescribing practices to minimize coprescription of drugs known to have a high probability of inducing serotonin syndrome. A computerized ordering system and medical software can check for possible interactions when multi-drug regimens are required. Currently, there are no established guidelines for the prevention of serotonin syndrome. Eventually, the application of pharmacogenomic principles may help identify and protect patients at risk of serotonin syndrome before the administration of serotonergic agents.

• #2 Prevention, recognition, and management of serotonin syndrome – PubMed

  https://pubmed.ncbi.nlm.nih.gov/20433130/

  Serotonin syndrome is a potentially life-threatening condition caused by excessive serotonergic activity in the nervous system. […] Most reported cases of serotonin syndrome are in patients using multiple serotonergic drugs or who have had considerable exposure to a single serotonin-augmenting drug. […] Most cases of serotonin syndrome are mild and may be treated by withdrawal of the offending agent and supportive care. […] If serotonin syndrome is recognized and complications are managed appropriately, the prognosis is favorable.

• #2 Serotonin syndrome: Preventing, recognizing, and treating it | Cleveland Clinic Journal of Medicine

  https://www.ccjm.org/content/83/11/810

  Prevention of serotonin syndrome begins with improving education and awareness in patients and healthcare providers. Patients should be primarily concerned with taking their medications carefully as prescribed and recognizing early signs and symptoms of serotonin toxicity. […] As use of antidepressants among an aging population continues to increase, and as physicians in multiple disciplines prescribe them for evolving indications (eg, duloxetine to treat osteoarthritis, diabetic neuropathy, fibromyalgia, and chemotherapy-induced peripheral neuropathy), healthcare providers need to be prepared to see more cases of serotonin syndrome and its deleterious effects. Physicians should be vigilant in minimizing unnecessary use of serotonergic agents and reviewing drug regimens regularly to limit poly-pharmacy.

• #3 Serotonin syndrome: Preventing, recognizing, and treating it | Cleveland Clinic Journal of Medicine

  https://www.ccjm.org/content/83/11/810

  Electronic ordering systems should be designed to detect and alert the prescriber to possible interactions that can potentiate serotonin syndrome, and to not place the order until the prescriber overrides the alert. Combinations of SSRIs and MAOIs have the highest risk for inducing severe serotonin syndrome and should always be avoided. […] If a patient is transitioning between serotonergic agents, physicians should observe a safe washout period to prevent overlap. Washout periods may differ among medications depending on their half-lives. For example, sertraline has a washout period of 2 weeks, while fluoxetine requires a washout period of 5 to 6 weeks. […] We believe that educating both patients and physicians regarding prevention will help minimize the risk for serotonergic syndrome and will improve efficiency in assessment and management should toxicity develop.

• #4 Serotonin Syndrome: Information for Physicians : Ottawa-Carleton, ON : eMentalHealth.ca

  https://primarycare.ementalhealth.ca/index.php?m=fpArticle&ID=49816

  Avoid using multiple serotonin medications, e.g. do not use more than one SSRI […] Avoid prescribing an SSRI along with a medication that blocks the metabolism of an SSRI […] Use electronic ordering systems and/or electronic medication databases to check for interactions.

• #5 Serotonin Syndrome: Patient Information : Toronto, ON : eMentalHealth.ca

  https://primarycare.ementalhealth.ca/Toronto/Serotonin-Syndrome-Information-for-Patients-and-Families/index.php?m=article&ID=85143

  Avoid using multiple serotonin medications, e.g. do not use more than one SSRI. […] Avoid prescribing an SSRI along with a medication that blocks the metabolism of an SSRI. […] Use electronic ordering systems and/or electronic medication databases to check for interactions.

• #6 Serotonin Syndrome | 5-Minute Clinical Consult

  https://www.unboundmedicine.com/5minute/view/5-Minute-Clinical-Consult/116962/all/Serotonin_Syndrome

  Consider drug-drug interactions when a multidrug regimen is required and avoid if possible. […] Caution patients about taking SSRIs with OTC medications (e.g., dextromethorphan) or herbal supplements (e.g., St. John wort) prior to consulting a physician. […] Avoid serotonergic agents for nonpsychiatric disorders (e.g., tramadol for pain relief).

• #7 Serotonin syndrome (serotonin toxicity) – UpToDate

  https://www.uptodate.com/contents/serotonin-syndrome-serotonin-toxicity/print

  Serotonin syndrome can be avoided by applying pharmacologic principles, educating clinicians, and modifying prescription practices. Multi-drug regimens should be avoided, if possible. Tramadol, meperidine, and dextromethorphan are strongly serotonergic opioids and should be avoided in patients taking other serotonergic agents. […] Specific drug-drug interactions may be determined using the drug interactions program included in UpToDate.

• #8 Serotonin Syndrome: Prophylactic Treatment With Cyproheptadine

  https://www.psychiatrist.com/pcc/serotonin-syndrome/

  Despite the numerous advantages of linezolid therapy, one disadvantage continuing to hinder its use is the risk of serotonin syndrome when coadministered with other serotonergic agents. […] The severity of the patients condition in conjunction with increased risk for serotonin syndrome warranted prophylactic treatment with cyproheptadine. […] The most effective approach to prevent serotonin syndrome is avoiding concomitant use of serotonergic agents when possible. […] Cyproheptadine may be a viable option for serotonin syndrome prophylaxis in high-risk patients who warrant immediate treatment with a serotonergic agent without sufficient time for a washout period. […] Cyproheptadine, a potent histamine (H1) and 5-HT2A receptor antagonist, is a widely used antidote for serotonin syndrome.

• #9 Serotonin Syndrome: Prophylactic Treatment With Cyproheptadine

  https://www.psychiatrist.com/pcc/serotonin-syndrome/

  While the incidence of serotonin syndrome is on the rise and the list of serotonergic agents grows, it is of benefit to explore the role of prophylactic treatment. […] On the basis of the substantial impact of 5-HT2A receptor agonism in the development of serotonin syndrome, cyproheptadine may be an ideal medication to use prophylactically in high-risk patients when an appropriate washout period is not feasible.

• #10

  https://journals.lww.com/jfmpc/fulltext/2024/13040/cyproheptadine_in_serotonin_syndrome__a.30.aspx

  For severe SS, admitted to the ICU, we followed the treatment regimen as described by Boyer et al. They recommend a loading dose of 12 mg, followed by 2 mg every 2 h if symptoms continue. It was followed by a maintenance dose of 8 mg of cyproheptadine every 6 h. This regimen of cyproheptadine was administered to all patients admitted to the ICU, in addition to other supportive treatments. […] The dosage schedule and effects of cyproheptadine on each patient are described in Table 2. All 10 patients who were brought to the ICU received the identical initial dosage regimen, which consisted of a loading dose of 12 mg followed by 2 mg every 2 h for at least 24 h. Those admitted to the ward had a lower initial dose. All patients admitted to the ward were given 4 mg of cyproheptadine three times each day. […] In light of this, at least some response to cyprohepatadine at a therapeutic dose within 24 h may serve as a diagnostic sign for the presence of SS. It can be included in the diagnostic criteria of SS.

• #11 Cyprohepta-doubts? Determining the Role of Cyproheptadine in Serotonin Syndrome | Poison Control | University of Utah Health

  https://poisoncontrol.utah.edu/news/2024/08/cyprohepta-doubts-determining-role-of-cyproheptadine-serotonin-syndrome

  Supportive care, such as benzodiazepines for sedation, is sufficient for most cases of serotonin syndrome. Paralysis via neuromuscular blockade may be necessary in severe cases. […] Evidence for benefit from cyproheptadine is extremely limited. […] Cyproheptadine should be considered adjunctive treatment and is not a replacement for adequate sedation with GABA-ergic agents. Most cases of serotonin syndrome resolve with supportive care measures alone. If considering cyproheptadine, it should be given as soon as possible. […] Additionally, many of the systematic reviews conducted over the last 10 years have not reported strong recommendations for cyproheptadine use and consider it as an adjunct for patients who continue to experience symptoms despite adequate supportive care. […] Cyproheptadine currently does not have FDA approval for the treatment of serotonin syndrome.

• #12 Detecting and Managing Serotonin Syndrome – Psychiatry Advisor

  https://www.psychiatryadvisor.com/features/detecting-and-managing-serotonin-syndrome/

  Dr Campbell-Taylor and Dr Chai both emphasized the critical role that psychiatrists can plan in preventing SS. […] Physicians and other prescribers should modify their prescription practices to avoid or at least minimize coprescription of drugs that have a high probability of inducing SS. […] Do not combine 2 serotonergic agents, such as an SSRI and SNRI, in treatment, and be vigilant during initiation of the medication or when increasing the dose, especially in patients naive to these drugs, Dr Chai warned. […] A computerized ordering system and medical software can ascertain whether there are potential interactions when multidrug regimens are required. […] It is critical to inquire about every item that your patient uses, including all prescription mediations, over-the-counter remedies, dietary supplements, and drugs of abuse, Dr Campbell-Taylor emphasized.

• #13 Detecting and Managing Serotonin Syndrome – Neurology Advisor

  https://www.neurologyadvisor.com/features/detecting-and-managing-serotonin-syndrome/

  Do not combine 2 serotonergic agents, such as an SSRI and SNRI, in treatment, and be vigilant during initiation of the medication or when increasing the dose, especially in patients naive to these drugs, Dr Chai warned. […] It is critical to inquire about every item that your patient uses, including all prescription mediations, over-the-counter remedies, dietary supplements, and drugs of abuse, Dr Campbell-Taylor emphasized. […] It therefore is incumbent on prescribers to inform patients about the risk for serotonin syndrome. […] I suggest that prescribers provide list of all products that patients should avoid while taking SSRIs, SNRIs, or other serotonergic agents, she advised. […] It is incumbent on all medical professionals to educate themselves and their patients and avoid prescribing these drugs whenever possible.

• #14 Serotonin Syndrome: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17687-serotonin-syndrome

  Its important to keep close tabs on all medications you take. Read all warnings on your drugs packaging or informational sheets. Theyll tell you if theres a risk of serotonin syndrome. […] Taking these precautions can help you and your healthcare team spot signs of serotonin syndrome early. Early identification may help you avoid more severe symptoms.

• #15 Serotonin Syndrome: Causes, Symptoms, and Treatment

  https://www.webmd.com/brain/serotonin-syndrome-causes-symptoms-treatments

  Be sure your doctor knows about all the prescription medications, over-the-counter drugs, supplements, herbs, and illegal drugs you take and any reactions you have, especially if you get prescriptions from more than one place. […] If you use more than one drug that affects your serotonin levels, know the symptoms of serotonin syndrome so you can watch for them. […] Make sure that you read all of the warnings on your drug’s packaging or the informational packet that comes with them. These will let you know if there’s any risk of serotonin syndrome. […] If you want to stop taking a medication, don’t do so until you’ve asked your doctor about the best way. […] If you take an antidepressant as well as a triptan for headaches, make sure your doctor keeps a close watch on you. This is especially true for SSRIs and SNRIs. Your risk of serotonin syndrome is usually very small, but it’s always better to be on the safe side. If you notice any symptoms, call your doctor as soon as possible.

• #16 Serotonin Syndrome Symptoms, Causes and Treatment – Summit Malibu

  https://summitmalibu.com/blog/serotonin-syndrome-symptoms-causes-and-treatment/

  Following all warning guidelines and only taking medications as prescribed by a doctor in the correct dosage is one of the best ways to prevent serotonin syndrome. […] When taking a new medication, always let your doctor know about any other drugs you might be taking, including supplements and recreational substances. […] Do not mix medications, substances, or supplements without consulting with a doctor first, and do not increase the dose above what is prescribed. […] If any health issues arise while taking a medication, speak with the doctor as soon as symptoms occur. […] Discontinuing the use of some prescription meds can cause other problems unless advised by a doctor. […] Yes, some supplements and herbal substances like St. Johns Wort, ginseng, and L-Tryptophan may increase the risk serotonin syndrome when taken in high doses or mixed with other serotonergic medications.

• #17 Serotonin syndrome – Symptoms & causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/serotonin-syndrome/symptoms-causes/syc-20354758

  Taking more than one serotonin-related medication or increasing your dose of a serotonin-related medication increases your risk of serotonin syndrome. Know what medications you take and share a complete list of your medications with your doctor or pharmacist. […] Be sure to talk to your doctor if you or a family member has experienced symptoms after taking a medication. […] Also talk to your doctor about possible risks. Don’t stop taking any medications on your own. If your doctor prescribes a new medication, make sure he or she knows about all the other medications you’re taking, especially if you receive prescriptions from more than one doctor. […] If you and your doctor decide the benefits of combining certain serotonin-level-affecting drugs outweigh the risks, be alert to the possibility of serotonin syndrome.

• #18 Serotonin syndrome: Causes, symptoms, and treatment

  https://www.medicalnewstoday.com/articles/326716

  Doctors can prevent serotonin syndrome by monitoring people taking high risk medications and prescribing treatments that have a low risk of interacting with a persons current medications. […] People can reduce their risk of developing serotonin syndrome by knowing their risk and staying informed. […] Populations at risk for serotonin syndrome include people who recently started or increased the dose of a medication that increases serotonin levels. Additionally, those who take more than one prescription medication, herbal supplement, or illicit drug that increases serotonin levels are also at a higher risk. […] People can speak with their doctors about the possible risks of developing serotonin syndrome. An individual should always inform their doctor about the medications and supplements they currently take. Doing this helps prevent potentially harmful drug interactions.

• #19 Could Your Medications Cause Serotonin Syndrome? | Banner

  https://www.bannerhealth.com/healthcareblog/better-me/could-your-medications-trigger-serotonin-syndrome

  Youre at higher risk for serotonin syndrome if you just started or increased a medication that raises serotonin levels or if you take more than one medication known to increase serotonin levels. […] Its crucial that you talk to your doctor or pharmacist about all your medications. That way, you can make adjustments if needed to avoid possible interactions. Avoiding the combination of multiple drugs is a critical step in prevention, Dr. Snow said.

• #20 What Is Serotonin Syndrome? Symptoms, Causes, Diagnosis, Treatment, and Prevention

  https://www.everydayhealth.com/depression-pictures/serotonin-syndrome-things-you-need-to-know.aspx

  You can prevent serotonin syndrome by keeping a close watch on all the medications you take and telling your provider about all medicines, supplements, or other substances you use, according to MedlinePlus. […] The best way to prevent this syndrome is to avoid multidrug regimens and to discontinue any [serotonin-containing] agent before starting another, says Kaye. […] Because people often seek care from multiple different physicians and may get medications from multiple pharmacies, your doctor or pharmacist may not know every medication that you are taking unless you tell them, adds Johnson-Arbor. […] Don’t abruptly stop taking any medicines you’re taking without first talking with your doctor, per Mayo Clinic.

• #21 Evaluating the risk of mild serotonin syndrome in primary care: a retrospective case series of patients with treatment-resistant depression – Jerjes – AME Case Reports

  https://acr.amegroups.org/article/view/10073/html

  Serotonin syndrome is an adverse drug reaction characterised by the excess of serotonin activity in the central nervous system. […] This study highlights the need for careful monitoring of serotonin syndrome in patients with treatment-resistant depression, especially in the case of polypharmacy. Early recognition of symptoms by primary care providers and close management ensure patient safety through proper medication management and education. […] Primary care physicians should enhance their vigilance for signs of serotonin syndrome and implement prompt, targeted interventions to improve patient outcomes and safety. […] Our findings are also consistent with those by Ruiz de Villa et al. and further supported by the studies of Montastruc et al. and Elli et al., which report cases of serotonin syndrome precipitated by polypharmacy, indicating a serious contribution of drug interactions to serotonin toxicity. These findings may suggest the need for clinical practice to be more vigilant, especially regarding prescription with combinations that are related to an increase in the risk of serotonin syndrome, such as opioids with serotonergic agents. […] According to Wang et al., prophylactic measures such as patient education combined with cautious and patient medication use management are significant in minimising the likelihood of the syndrome.

• #22 Serotonin syndrome: a spectrum of toxicity | BJPsych Advances | Cambridge Core

  https://www.cambridge.org/core/journals/bjpsych-advances/article/serotonin-syndrome-a-spectrum-of-toxicity/BB07FCAF5DC69DF5FFC0AEB113147A9E

  We have an aging population often treated with complex regimens of multiple drugs. This poses particular challenges if several medical conditions co-occur. Reference Lingam and ScottLingam Scott (2002) state that 10 60% of patients do not take their antidepressant medication as prescribed; introduction of the SSRIs appears to have had little impact on this. Patterns of adherence to prescribed antidepressants vary from taking excessive amounts sporadically, to periodic use, to frequent stopstarts, to abrupt cessation; around a third of patients who discontinue their medication may not reveal this to their doctor. There is thus not only the risk of toxicity but of experiencing discontinuation symptoms, which include sleep disturbance, agitation, anxiety and depression (Reference Demyttenaere and HaddadDemyttenaere 2000). Patient- and/or illness-related factors may contribute to this; sensitively exploring patients attitudes, associated health beliefs and treatment expectations may be helpful in assessing the degree of medication adherence. Routine enquiry about various foods, including caffeine consumption, and the use of recreational drugs may assist in the face of apparent treatment non-response before prescribing second- or even third-line medication. The importance of advising patients against mixing other substances with prescribed drugs should not be underestimated. Medication reconciliation and communication with other people who may be prescribing for patients are key.

• #23

  https://step2.medbullets.com/evidence/20433130

  Serotonin syndrome is a potentially life-threatening condition caused by excessive serotonergic activity in the nervous system. […] Most cases of serotonin syndrome are mild and may be treated by withdrawal of the offending agent and supportive care. […] If serotonin syndrome is recognized and complications are managed appropriately, the prognosis is favorable.

• #24 Serotonin syndrome: a rare undiagnosed cause of hyperpyrexia | The Egyptian Journal of Internal Medicine | Full Text

  https://ejim.springeropen.com/articles/10.1186/s43162-023-00223-2

  Serotonin syndrome is a rare cause of hyperpyrexia, it should be suspected in all patients receiving serotonergic medicine, a single serotonergic agent usually causes mild or moderate serotonin toxicity while severe serotonin syndrome may develop after the addition of a second serotonergic drug. […] Early diagnosis of mild serotonin syndrome prevents the development of severe life-threatening serotonin syndrome so it is suggested that every patient on the serotonergic drug should be examined for the presence of hyperreflexia, tremor, and clonus.

• #25 Serotonin Syndrome: Symptoms, Causes, Diagnosis, Treatment

  https://www.healthline.com/health/serotonin-syndrome

  You cannot always prevent serotonin syndrome. Make sure your doctor knows what medications you’re taking. Your doctor should closely monitor you if you’re taking a combination of medications known to increase serotonin levels. This is especially important right after you start a new medication or right after your doctor increases your dosage. […] The FDA requires warning labels on products to warn people of the risk of serotonin syndrome.

• #26 Serotonin syndrome: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/007272.htm

  Always tell your providers which medicines you take. People who take triptans with SSRIs or SSNRIs should be closely followed, especially right after starting a medicine or increasing its dosage.

• #27 FF #403 Serotonin Syndrome in Palliative Care | Palliative Care Network of Wisconsin

  https://www.mypcnow.org/fast-fact/serotonin-syndrome-in-palliative-care/

  Awareness and Prevention: The prevalence of SS among seriously ill patients is not known. In the palliative care or end-of-life setting, the potential for symptomatic benefit of culprit medications often outweighs the risk of adverse events related to SS, since it is felt to be a rare complication. So rather than avoiding all culprit medications in the seriously ill, clinicians should have increased awareness of SS among those on culprit medications, as doing so should improve prevention and early detection (1). Even mild cases of SS may exacerbate pre-existing symptoms caused by the underlying disease, with potential worsening of quality of life. Therefore, collaboration with a clinical pharmacist and/or a careful medication reconciliation also is recommended when prescribing multiple serotonergic agents (13).

• #28 SSRIs and Serotonin Syndrome

  https://www.uspharmacist.com/article/ssris-and-serotonin-syndrome

  Awareness of the serotonergic potential of various medications is the primary method for preventing serotonin syndrome. […] The pharmacist plays a critical role in prevention. This role involves checking medication lists for potential toxicity and contacting prescribers when there is a potential for problems. […] Since serotonin syndrome is caused by a cumulative effect, clinical judgment is essential for determining when the serotonergic load is sufficient to be potentially harmful. […] The consultant or clinical pharmacist is a key link in the prevention and management of serotonin syndrome related to SSRIs and other medications.

• #29 Detecting and Managing Serotonin Syndrome – Psychiatry Advisor

  https://www.psychiatryadvisor.com/features/detecting-and-managing-serotonin-syndrome/

  It therefore is incumbent on prescribers to inform patients about the risk for serotonin syndrome. […] I suggest that prescribers provide list of all products that patients should avoid while taking SSRIs, SNRIs, or other serotonergic agents, she advised. […] The implications of this widespread SSRI use are staggering, Dr Campbell-Taylor said. It is incumbent on all medical professionals to educate themselves and their patients and avoid prescribing these drugs whenever possible. […] Evidence-based psychotherapies, such as cognitive behavioral therapy, are increasingly being regarded as potential first-line approaches to patients with mood disorders, and their use should be increased, together with other nonpharmacologic interventions, she advised.

• #30 Serotonin Syndrome | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/28918

  Serotonin syndrome may be a consequence of therapeutic medication use, accidental interactions between medications and recreational drugs, or an intentional overdose. […] Preventing serotonin syndrome involves careful monitoring of medication use, avoiding the concurrent use of multiple serotonin-increasing drugs, and consulting with healthcare professionals if concerns about drug interactions are apparent. […] Discontinuation of all serotonergic agents is the first step in treating serotonin syndrome. […] After discontinuation of serotonergic agents, supportive care to normalize the vital signs is recommended during the serotonergic agent’s detox from the body. […] The administration of an antidote (serotonin antagonists) is not required in all cases of serotonin syndrome. However, if supportive measures, vital signs management, and chemical sedation do not adequately treat serotonin syndrome, then antidotes can be considered the next step.

• #31 FF #403 Serotonin Syndrome in Palliative Care | Palliative Care Network of Wisconsin

  https://www.mypcnow.org/fast-fact/serotonin-syndrome-in-palliative-care/

  If SS is identified, serotonergic medications should be carefully reviewed and then tapered or discontinued based on the patient’s symptom burden and goals of care. Mild cases often improve within 24 hours after stopping the causative agents(s) and usually do not require hospital admission or additional intervention (8). For moderate to severe cases which usually involve hypertonicity, hyperthermia, autonomic instability, or progressive cognitive changes, hospitalization or close clinical supervision is suggested (4).

• #32 What Is Serotonin Syndrome? – Consensus: AI Search Engine for Research

  https://consensus.app/home/blog/what-is-serotonin-syndrome/

  Serotonin syndrome is a complex and potentially dangerous condition resulting from excessive serotonin activity in the brain. […] Understanding the mechanisms, symptoms, and risk factors associated with serotonin syndrome is essential for its prevention and early recognition. […] Further research is needed to explore the intricate interactions between serotonin and other neuromodulators, which could lead to improved therapeutic strategies for managing this condition.

Zobacz więcej